Bavarian Nordic
Bavarian Nordic develops and markets contagion vaccines. It focuses on the further development of pox vaccines.
BioM AG
BioM, a service, consulting and financing company, pursues the goal of promoting the development of the Munich biotech region to help it become one of the leading centres in Europe.
GenPharmTox
GenPharmTox offer international companies from the chemical and pharmaceutical industry as well as biotech companies innovative technologies for the analysis and risk assessment of compounds, drugs and chemicals.
Gentana
Gentana GmbH develops customer-specific technologies for functional genome research.
Probiodrug
Probiodrug develops new concepts for the treatment of age-related diseases of the metabolism as well as the nervous and immune system.
Sygnis Pharma AG
SYGNIS Pharma AG researches, develops and markets drugs for diseases ofthe central nervous system such as stroke, Huntington’s Disease, Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS), for which there issignificant medical need. The company takes a dual approach to therapy thatcovers both acute treatment and regeneration of the nervous system.